IL126175A - Pharmaceutical compositions containing endothelin antagonists and novel endothelin antagonists - Google Patents

Pharmaceutical compositions containing endothelin antagonists and novel endothelin antagonists

Info

Publication number: IL126175A
Authority: IL; Israel
Prior art keywords: endothelin antagonists; pharmaceutical compositions; compositions containing; novel; antagonists
Prior art date: 1996-04-04

Application number

IL12617597A

Other languages

English (en)

Other versions

IL126175A0 (en

Original Assignee

Banyu Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-04-04

Filing date

1997-03-19

Publication date

2003-05-29

1997-03-19 Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd

1999-05-09 Publication of IL126175A0 publication Critical patent/IL126175A0/xx

2003-05-29 Publication of IL126175A publication Critical patent/IL126175A/xx

Links

102000002045 Endothelin Human genes 0.000 title 2
108050009340 Endothelin Proteins 0.000 title 2
239000005557 antagonist Substances 0.000 title 2
ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 title 2
239000008194 pharmaceutical composition Substances 0.000 title 1
206010019280 Heart failures Diseases 0.000 abstract 1
208000009982 Ventricular Dysfunction Diseases 0.000 abstract 1
239000002308 endothelin receptor antagonist Substances 0.000 abstract 1
230000006815 ventricular dysfunction Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Materials For Photolithography (AREA)
Photosensitive Polymer And Photoresist Processing (AREA)

IL12617597A 1996-04-04 1997-03-19 Pharmaceutical compositions containing endothelin antagonists and novel endothelin antagonists IL126175A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1488296P	1996-04-04	1996-04-04
PCT/US1997/003737 WO1997037665A1 (en)	1996-04-04	1997-03-19	Method of treating heart failure with endothelin antagonists

Publications (2)

Publication Number	Publication Date
IL126175A0 IL126175A0 (en)	1999-05-09
IL126175A true IL126175A (en)	2003-05-29

Family

ID=21768326

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12617597A IL126175A (en)	1996-04-04	1997-03-19	Pharmaceutical compositions containing endothelin antagonists and novel endothelin antagonists

Country Status (25)

Country	Link
US (3)	US5834483A (de)
EP (1)	EP0906108B1 (de)
JP (2)	JP3345891B2 (de)
KR (1)	KR20000005178A (de)
CN (1)	CN1215335A (de)
AT (1)	ATE297739T1 (de)
AU (1)	AU723351B2 (de)
BG (1)	BG102716A (de)
BR (1)	BR9708525A (de)
CA (1)	CA2249330C (de)
CZ (1)	CZ296098A3 (de)
DE (1)	DE69733557T2 (de)
EA (1)	EA003587B1 (de)
EE (1)	EE9800315A (de)
ES (1)	ES2241047T3 (de)
HU (1)	HUP9903893A3 (de)
IL (1)	IL126175A (de)
IS (1)	IS4847A (de)
NO (1)	NO984564L (de)
NZ (1)	NZ331789A (de)
PL (1)	PL329077A1 (de)
SK (1)	SK130098A3 (de)
TR (1)	TR199801988T2 (de)
UA (1)	UA50761C2 (de)
WO (1)	WO1997037665A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR199801988T2 (xx) *	1996-04-04	2000-08-21	Banyu Pharmaceutical Co.,Ltd.	Kalp yetmezli�inin endotelin antagonistleri ile tedavisi i�in y�ntem.
JPH11514676A (ja) *	1996-08-09	1999-12-14	メルクエンドカンパニーインコーポレーテッド	立体選択的脱酸素化反応
ATE259800T1 (de)	1998-01-21	2004-03-15	Banyu Pharma Co Ltd	Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate
US8168616B1 (en)	2000-11-17	2012-05-01	Novartis Ag	Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
WO2004060885A1 (ja) *	2002-12-27	2004-07-22	Kaneka Corporation	光学活性２−チオメチル−３−フェニルプロピオン酸誘導体およびその合成中間体の製造法
KR20150132601A (ko)	2003-11-17	2015-11-25	노파르티스 아게	디펩티딜 펩티다제 ⅳ 억제제의 용도
GB0327839D0 (en)	2003-12-01	2003-12-31	Novartis Ag	Organic compounds
NZ549535A (en)	2004-03-17	2010-11-26	Novartis Ag	Use of aliskiren for treating renal and other disorders
US20100040666A1 (en)	2005-06-24	2010-02-18	Hiroshi Azuma	Method for Control of Drug Elution Rate and Composition for Coating of Drug-Eluting Stent
AR080683A1 (es)	2010-03-16	2012-05-02	Novartis Ag	Composiciones farmaceuticas de aliskiren y metodos de administracion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4971959A (en) *	1987-04-14	1990-11-20	Warner-Lambert Company	Trisubstituted phenyl analogs having activity for congestive heart failure
GB9007762D0 (en) *	1990-04-05	1990-06-06	Beecham Group Plc	Novel compounds
US5565485A (en) *	1993-03-19	1996-10-15	Merck & Co., Inc.	Biphenyl compounds useful or endothelin antagonists
SK130595A3 (en)	1993-04-27	1996-06-05	Smithkline Beecham Corp	New indane and indene derivatives, preparing method, pharmaceutical compositions containing them and their use
US5571813A (en) *	1993-06-10	1996-11-05	Beiersdorf-Lilly Gmbh	Fused pyrimidine compounds and their use as pharmaceuticals
US5389620A (en) *	1993-08-18	1995-02-14	Banyu Pharmaceutical Co., Ltd.	Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
WO1995005374A1 (en) *	1993-08-18	1995-02-23	Banyu Pharmaceutical Co., Ltd.	Fused heteroaromatic cyclopentene derivative having endothelin-antagonist activity
US5658943A (en) *	1995-01-05	1997-08-19	Warner-Lambert Company	Phenylalanine derivatives as endothelin antagonists
TR199801988T2 (xx) *	1996-04-04	2000-08-21	Banyu Pharmaceutical Co.,Ltd.	Kalp yetmezli�inin endotelin antagonistleri ile tedavisi i�in y�ntem.

1997
- 1997-03-19 TR TR1998/01988T patent/TR199801988T2/xx unknown
- 1997-03-19 KR KR1019980707850A patent/KR20000005178A/ko not_active Ceased
- 1997-03-19 HU HU9903893A patent/HUP9903893A3/hu unknown
- 1997-03-19 PL PL97329077A patent/PL329077A1/xx unknown
- 1997-03-19 UA UA98105222A patent/UA50761C2/uk unknown
- 1997-03-19 EA EA199800889A patent/EA003587B1/ru not_active IP Right Cessation
- 1997-03-19 WO PCT/US1997/003737 patent/WO1997037665A1/en not_active Ceased
- 1997-03-19 AU AU22025/97A patent/AU723351B2/en not_active Ceased
- 1997-03-19 EE EE9800315A patent/EE9800315A/xx unknown
- 1997-03-19 SK SK1300-98A patent/SK130098A3/sk unknown
- 1997-03-19 DE DE69733557T patent/DE69733557T2/de not_active Expired - Lifetime
- 1997-03-19 NZ NZ331789A patent/NZ331789A/xx unknown
- 1997-03-19 CN CN97193645A patent/CN1215335A/zh active Pending
- 1997-03-19 ES ES97914955T patent/ES2241047T3/es not_active Expired - Lifetime
- 1997-03-19 BR BR9708525A patent/BR9708525A/pt not_active Application Discontinuation
- 1997-03-19 AT AT97914955T patent/ATE297739T1/de not_active IP Right Cessation
- 1997-03-19 CA CA002249330A patent/CA2249330C/en not_active Expired - Fee Related
- 1997-03-19 CZ CZ982960A patent/CZ296098A3/cs unknown
- 1997-03-19 EP EP97914955A patent/EP0906108B1/de not_active Expired - Lifetime
- 1997-03-19 IL IL12617597A patent/IL126175A/xx not_active IP Right Cessation
- 1997-03-19 JP JP53619497A patent/JP3345891B2/ja not_active Expired - Fee Related
- 1997-03-26 US US08/824,848 patent/US5834483A/en not_active Expired - Fee Related
1998
- 1998-08-11 US US09/132,514 patent/US6087360A/en not_active Expired - Lifetime
- 1998-08-21 BG BG102716A patent/BG102716A/xx unknown
- 1998-09-15 IS IS4847A patent/IS4847A/is unknown
- 1998-09-30 NO NO984564A patent/NO984564L/no not_active Application Discontinuation
2000
- 2000-02-22 US US09/507,666 patent/US6380195B1/en not_active Expired - Fee Related
2001
- 2001-12-07 JP JP2001374870A patent/JP2002220337A/ja active Pending

Also Published As

Publication number	Publication date
EE9800315A (et)	1999-06-15
ATE297739T1 (de)	2005-07-15
CA2249330C (en)	2005-08-09
EP0906108A4 (de)	2000-12-06
ES2241047T3 (es)	2005-10-16
EP0906108A1 (de)	1999-04-07
CN1215335A (zh)	1999-04-28
NO984564D0 (no)	1998-09-30
EA199800889A1 (ru)	1999-04-29
HUP9903893A3 (en)	2001-05-28
DE69733557D1 (de)	2005-07-21
IS4847A (is)	1998-09-15
HUP9903893A2 (hu)	2001-04-28
KR20000005178A (ko)	2000-01-25
SK130098A3 (en)	1999-05-07
NO984564L (no)	1998-12-04
AU2202597A (en)	1997-10-29
WO1997037665A1 (en)	1997-10-16
TR199801988T2 (xx)	2000-08-21
US6087360A (en)	2000-07-11
CA2249330A1 (en)	1997-10-16
UA50761C2 (uk)	2002-11-15
JP2002220337A (ja)	2002-08-09
IL126175A0 (en)	1999-05-09
US6380195B1 (en)	2002-04-30
EP0906108B1 (de)	2005-06-15
US5834483A (en)	1998-11-10
JP3345891B2 (ja)	2002-11-18
BR9708525A (pt)	1999-08-03
EA003587B1 (ru)	2003-06-26
PL329077A1 (en)	1999-03-15
JP2000510824A (ja)	2000-08-22
AU723351B2 (en)	2000-08-24
CZ296098A3 (cs)	1999-06-16
BG102716A (en)	1999-09-30
DE69733557T2 (de)	2005-11-03
NZ331789A (en)	2000-05-26

Legal Events

Date	Code	Title	Description
2003-11-23	FF	Patent granted
2005-07-25	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
CA2289717A1 (en)	1998-11-12	Novel therapy for constipation
IL147852A0 (en)	2002-08-14	Chemokine receptor antagonists and pharmaceutical compositions containing the same
EP1428821A8 (de)	2005-01-26	Piperidin-4-ylamine mit analgetischer Wirksamkeit
UA49869C2 (uk)	2002-10-15	Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора
MY119403A (en)	2005-05-31	Novel compounds with analgesic effect.
HRP20010119B1 (hr)	2008-05-31	Sprječavanje stvaranja sluzi u dišnim putevima primjenom antagonista egf-r
LTIP702A (en)	1995-01-31	A slimming pharmaceutical composition
BR9510168A (pt)	1997-10-14	Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição
IL137266A0 (en)	2001-07-24	Heterocyclic chemokine receptor antagonists and pharmaceutical compositions containing the same
CA2378613A1 (en)	2001-01-11	Selective iglur5 receptor antagonists for the treatment of migraine
DE69637050D1 (de)	2007-06-06	Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer
WO2001030802A3 (en)	2002-02-14	Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
EP0902789A4 (de)	1999-04-14
MY109309A (en)	1997-01-31	Improvements in or relating to somatostatins
EP0911331A3 (de)	2000-01-19	Substutierte Dibenzoxazepinverbindungen, pharmazeutische Zusammensetzungen, und Anwendungsmethoden
HU9700654D0 (en)	1997-05-28	Antitussive compositions
IL126175A0 (en)	1999-05-09	Method or treating heart failure with endothelin antagonists and pharmaceutical compositions containing the same
IL136733A0 (en)	2001-06-14	Pharmaceutical composition containing sibutramine and orlistat
WO2000048446A3 (en)	2001-02-08	Use of antagonists of pg-e for the treatment of neuropathic pain
IL127851A0 (en)	1999-10-28	Inhibition of TNF activity
MY126321A (en)	2006-09-29	Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
EP1050303A3 (de)	2003-01-15	Methoden und Zusammenstellungen zur Behandlung von altersgebundenen Verhaltensstörungen von Haustieren
BG103905A (en)	2000-07-31	New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
ATE245998T1 (de)	2003-08-15	Somatostatin agoniste zur reduzierung von körpergewicht
HUP9801894A2 (hu)	1999-11-29	Dofetilid alkalmazása kongesztív szívpanaszok kezelésére szolgáló gyógyszerkészítmények előállítására